Fertility-sparing treatment in uterine cancer
The fertility-sparing treatment is not the standard of care but is accepted worldwide as an option in women desiring pregnancy. It should be performed in centers with expertise and where close collaboration between reproductive specialists, oncologists and pathologists is possible.
The fertility-sparing approach involves medical treatment with a progesterone preparation in combination with periodic monitoring of the endometrium by biopsy.
If no traces of the uterine cancer are detected by the 6th month of medical treatment, attempts to become pregnant can begin. While trying to get pregnant, the reproductive specialist will continue to monitor the condition of the endometrium once every 3-6 months.
If, by the 6-th month of medical treatment, the cancer cells are still detected, it is recommended to move on to surgical treatment.